A collaboration of researchers from across the USA has uncovered two closely related cytokines that may help explain why certain patients develop progressive multiple sclerosis, the most severe form of the disease.
Researchers have developed a 3D, all-human, in vitro model to help overcome challenges in delivering drugs to the brain.
Identification of loci associated with risk of Parkinson’s disease adds to understanding of genetic factors contributing to development of the disease
Novel research has suggested the gut microbiome is involved in multiple sclerosis and could be a treatment target.
Data from a head-to-head, open-label study were presented at the 18th Congress of the International Headache Society in Vancouver (Canada, 7–10 September 2017).
Neural activity resembling epileptic events has been found in multiple GCaMP6-expressing transgenic mouse lines, potentially complicating interpretation of neural activity in the lines.
Using FTIR spectroscopy and chemometirc techniques, researchers were able to successfully diagnose and differentiate between various neurodegenerative diseases including Alzheimer’s disease.
Novel research clarifies the effects of long-term schizophrenia medication on cognitive function.
In a new biomarker study, RNA transcripts have shown potential as diagnostic markers of Alzheimer’s disease.
Join us as we honor those living with dementia, as well as celebrate the scientists, clinicians, charities and fundraisers working to beat this disease.